Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.51 USD | -4.50% | -12.58% | -16.78% |
May. 23 | U.S. FDA advisers back approval for Guardant's cancer test | RE |
May. 23 | Guardant Health Shares Halted; FDA Panel to Review Premarket Application of Colorectal Cancer Screening Test | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.78% | 2.75B | |
-26.90% | 9.87B | |
-17.50% | 2.13B | |
-24.25% | 1.65B | |
+64.58% | 1.47B | |
+31.92% | 811M | |
-5.02% | 733M | |
-29.59% | 510M | |
+0.20% | 300M | |
-28.40% | 166M |
- Stock Market
- Equities
- GH Stock
- News Guardant Health, Inc.
- Transcript : Guardant Health, Inc. Presents at Citi’s 2023 Healthcare Services, Medtech, Tools & HCIT Conference, Mar-01-2023 03